Skip to main content
Login

Changes to Existing Law

SC813celebrating Solventum's expansion of its Brookings, South Dakota, manufacturing facility.

Changes from Amendments

What changed between bill versions as it moved through the Legislature.

IntroducedEnrolled+19 -192

The amendment corrected a typographical error, changing "274,000-square-9 foot" to "274,000-square-foot" to accurately describe the size of the building addition. This is a minor technical fix that does not alter the bill's purpose of celebrating Solventum's expansion in Brookings.

26.1034.11 101st Legislative Session SC813 2026 South Dakota Legislature Senate Commemoration 813 Introduced by: Senators Reed and Crabtree and Representatives Heermann, DeGroot, Reisch, and Walburg Underscores indicate new language. Overstrikes indicate deleted language. A LEGISLATIVE COMMEMORATION celebrating Solventum's expansion of its 1 Brookings, South Dakota, manufacturing facility. 2 WHEREAS, Solventum is a global healthcare innovation company dedicated to advancing 3 medical technologies, improving patient outcomes, and strengthening healthcare delivery 4 systems; and 5 WHEREAS, Solventum maintains a significant operational presence in Brookings, South 6 Dakota, and has completed a $220 million expansion of its Brookings facility, representing a 7 substantial investment in the local community and the state of South Dakota; and 8 WHEREAS, the expansion included the construction of an approximately 274,000-square-9 foot 274,000-square-foot building addition, which incorporates sixteen new loading docks, enhancing the 10 company's operational and distribution capabilities; and 11 WHEREAS, Solventum's expansion project in Brookings demonstrates a commitment to 12 the local economy and a confidence in South Dakota's prosperous business environment; 13 NOW, THEREFORE, BE IT COMMEMORATED, by the One Hundred First Legislature of the 14 State of South Dakota, that on April 2, 2026, Solventum will officially open its expanded 15 facility in Brookings, South Dakota, and continue its commitment to creating innovative 16 products and providing services that transform patient experiences and positively impact 17 millions of lives. 18